🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Hundreds of people set to benefit after a new immunotherapy treatment for advanced lung cancer was recommended today. Find out more about atezolizumab: nice.org.uk/guidance/indev…

People with a rare, life-threatening skin condition are set to benefit after we recommended a new targeted treatment today. Find out more about spesolimab for treating generalised pustular #psoriasis flares⤵️ nice.org.uk/guidance/indev…

Deal agreed for continued access to cerliponase alfa for treating CLN2 Batten disease. The draft guidance, out for consultation, does not at present recommend the treatment’s use for future patients. Learn more⤵️ nice.org.uk/news/articles/…

Health and care professionals, stay updated with NICE's latest guidelines via our WhatsApp updates channel. 📱On mobile? Join here: whatsapp.com/channel/0029Va… 🖥️On desktop? Scan the QR code in the video. 🔔Once subscribed hit the bell to stay notified.

Have you received a liver transplant after being on a waiting list? Help shape the future of transplant technology. Join NICE as a lay specialist committee member to evaluate machine perfusion devices that could improve liver transplant outcomes⬇️ nice.org.uk/get-involved/o…

Join our NICE Advice seminar (24 June) for pharma teams and consultancies, to strengthen your submission strategy. Learn about: ▪️real-world data & AI ▪️health inequalities ▪️presenting surrogate outcomes. Develop stronger evidence with expert support⤵️ eventbrite.co.uk/e/strengthenin…

Find out about our priorities and work in health and social care at tomorrow's online public board meeting. Register here: nice.org.uk/event/pbmay_20…

We recommend new medicines and treatments that are both clinically and cost effective, ensuring fair and effective use of NHS resources. Find out how NICE makes decisions and how they’re made independently, transparently and fairly⬇️ indepth.nice.org.uk/how-nice-makes…

📢Our updated technology evaluation methods will help tackle health inequalities across communities. Read how NICE is ensuring fairer health outcomes in our blog post: nice.org.uk/news/blogs/hea… #HealthInequalities

🆕NICE recommends marstacimab as the first once-weekly subcutaneous (under the skin) injection for people aged 12+ with severe haemophilia B. This replaces factor 9 replacement therapy, often requiring infusions every few days⤵️

Dostarlimab, recommended in final guidance, is set to benefit around 570 people with certain types of primary advanced or recurrent endometrial cancer. Clinical trials show that adding dostarlimab to standard chemotherapy helps women stay well longer⤵️ nice.org.uk/guidance/ta106…

The lives of thousands of people with chronic kidney disease could be changed for the better after we recommended a new treatment option for use in the NHS. Learn more about sparsentan for treating primary IgA nephropathy: nice.org.uk/news/articles/…

Have you received a liver transplant after being on a waiting list? Help shape the future of transplant technology. Join NICE as a lay specialist committee member to evaluate machine perfusion devices that could improve liver transplant outcomes⬇️ nice.org.uk/get-involved/o…

🔍What is NICE's severity modifier? Find out why we introduced it and how it's: ✅Ensuring our technology appraisals are fair & effective ✅Benefitting people with a broader range of conditions ✅Leading to more cancer treatments being recommended 🔗indepth.nice.org.uk/what-is-nices-…

🆕targeted combination treatment for advanced bowel cancer. Nivolumab with ipilimumab has been recommended in final guidance today. Find out more⤵️ nice.org.uk/guidance/ta106…

📥Update for primary care published Read about: ▪️a digital therapy recommended for tic disorders in children - a first for the NHS ▪️updates on asthma inhalers reducing carbon emissions ▪️and new clinical knowledge summaries. Read the full newsletter⤵️ us8.campaign-archive.com/?e=d9fa96e2a1&…

Thousands of people with #Crohns disease could be set to benefit from a new targeted treatment option recommended by NICE today. Find out more about mirikizumab: nice.org.uk/guidance/indev…

NICE recommends expanding the number of people who are eligible to receive a drug to treat chronic kidney disease. Find out more about dapagliflozin: nice.org.uk/guidance/indev… #NICENews